TheEdgeResearch
Home / Stocks / CBGL

Cannabis Global Inc. (CBGL)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$656,420
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
80.29
52-Wk Range
0.00001-0.0003
CEO
Edward F. Manolos
Country
US
Currency
USD

Cannabis Global Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Los Angeles, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $656,420. On trailing twelve-month figures it carries a trailing P/E of -3.40, a net margin of 0.0%. Its beta of 80.29 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-3.40
Price / Sales
0.00
Price / Book
-0.14
EV / EBITDA
-248.78
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
-0.80
Current ratio
0.05
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
3
IPO date
2008-06-19
Headquarters
Los Angeles, CA, US
About Cannabis Global Inc.

Cannabis Global, Inc. focuses on the creating and commercialization of engineered technologies to deliver hemp extracts and cannabinoids to the human body. The company offers cannabis flower packaged, pre-rolls, and edible products to cannabis retailers and distributors; and Comply Bag, a solution for cannabis storage, transport, and tracking. It also provides managerial services in areas of the regulated hemp and cannabis industries. The company was formerly known as MCTC Holdings, Inc. and changed its name to Cannabis Global, Inc. in December 2019. Cannabis Global, Inc. was incorporated in 2005 and is headquartered in Los Angeles, California.

Comparable companies

Cannabis Global Inc. is most often compared with the following Healthcare names:

ATTBFBIOIFHENCINLBINSDISOLFLRDSFOWCPREFGTRCNF
More research on CBGL
CBGL technical analysis CBGL TheEdge Score Compare against peers
Open full interactive analysis & DCF →